## 3 Results and Discussion
### Bioactive Compounds
\begin{table}
\begin{tabular}{c c c c c c c} \hline \hline
**Treatment** & **TPC (mg GAE/g)** & **TFC (mg CE/g)** & **AA (\%)** \\ \hline HA40 & 15.70 \(\pm\) 0.52 & 12.52 \(\pm\) 0.69 & 67.72 \(\pm\) 0.11 \\ HA55 & 11.42 \(\pm\) 0.45 & 10.14 \(\pm\) 0.41 & 68.01 \(\pm\) 0.03 \\ HA70 & 9.18 \(\pm\) 0.11 & 7.67 \(\pm\) 0.32 & 68.26 \(\pm\) 0.09 \\ IR250 & 21.84 \(\pm\) 0.15 & 21.64 \(\pm\) 0.83 & 68.44 \(\pm\) 0.11 \\ IR500 & 18.37 \(\pm\) 0.36 & 17.81 \(\pm\) 0.65 & 68.39 \(\pm\) 0.04 \\ IR750 & 7.04 \(\pm\) 0.04 & 5.44 \(\pm\) 0.21 & 68.23 \(\pm\) 0.06 \\ \hline HA40-IR250 & 6.71 \(\pm\) 0.12 & 5.07 \(\pm\) 0.23 & 67.53 \(\pm\) 0.08 \\ HA40-IR500 & 6.05 \(\pm\) 0.04 & 4.33 \(\pm\) 0.17 & 67.36 \(\pm\) 0.07 \\ HA40-IR750 & 6.16 \(\pm\) 0.03 & 4.45 \(\pm\) 0.11 & 67.36 \(\pm\) 0.1 \\ HA55-IR250 & 5.61 \(\pm\) 0.23 & 3.83 \(\pm\) 0.08 & 66.50 \(\pm\) 0.03 \\ HA55-IR800 & 6.49 \(\pm\) 0.18 & 4.82 \(\pm\) 0.10 & 66.51 \(\pm\) 0.05 \\ HA55-IR750 & 5.61 \(\pm\) 0.19 & 3.83 \(\pm\) 0.14 & 66.50 \(\pm\) 0.08 \\ HA70-IR250 & 5.50 \(\pm\) 0.06 & 3.71 \(\pm\) 0.09 & 66.50 \(\pm\) 0.09 \\ HA70-IR500 & 4.25 \(\pm\) 0.08 & 4.58 \(\pm\) 0.18 & 67.88 \(\pm\) 0.03 \\ HA70-IR750 & 8.50 \(\pm\) 0.24 & 7.17 \(\pm\) 0.34 & 67.39 \(\pm\) 0.04 \\ \hline HA40+IR250 & 10.46 \(\pm\) 0.16 & 9.40 \(\pm\) 0.22 & 67.42 \(\pm\) 0.04 \\ HA40+IR800 & 7.52 \(\pm\) 0.25 & 6.06 \(\pm\) 0.20 & 67.38 \(\pm\) 0.09 \\ HA40+IR750 & 7.36 \(\pm\) 0.29 & 5.44 \(\pm\) 0.26 & 67.38 \(\pm\) 0.05 \\ HA55+IR250 & 11.85 \(\pm\) 0.12 & 10.26 \(\pm\) 0.29 & 67.44 \(\pm\) 0.03 \\ HA55+IR500 & 13.80 \(\pm\) 0.17 & 12.37 \(\pm\) 0.25 & 67.04 \(\pm\) 0.03 \\ HA55+IR750 & 15.14 \(\pm\) 0.19 & 14.10 \(\pm\) 0.28 & 67.06 \(\pm\) 0.06 \\ HA70+IR250 & 3.56 \(\pm\) 0.02 & 3.65 \(\pm\) 0.21 & 67.35 \(\pm\) 0.02 \\ HA70+IR500 & 7.46 \(\pm\) 0.15 & 5.69 \(\pm\) 0.22 & 66.95 \(\pm\) 0.07 \\ HA70+IR750 & 3.14 \(\pm\) 0.19 & 5.00 \(\pm\) 0.24 & 68.02 \(\pm\) 0.07 \\ \hline IR250+HA40 & 7.35 \(\pm\) 0.20 & 5.56 \(\pm\) 0.12 & 67.72 \(\pm\) 0.08 \\ IR250+HA55 & 5.54 \(\pm\) 0.24 & 3.59 \(\pm\) 0.32 & 67.69 \(\pm\) 0.05 \\ IR250+HA70 & 6.99 \(\pm\) 0.11 & 5.32 \(\pm\) 0.09 & 67.72 \(\pm\) 0.07 \\ IR500+HA40 & 6.99 \(\pm\) 0.13 & 5.32 \(\pm\) 0.15 & 67.72 \(\pm\) 0.08 \\ IR500+HA55 & 6.33 \(\pm\) 0.09 & 4.58 \(\pm\) 0.18 & 67.71 \(\pm\) 0.09 \\ IR500+HA70 & 4.00 \(\pm\) 0.02 & 4.20 \(\pm\) 0.06 & 68.19 \(\pm\) 0.07 \\ IR250+HA40 & 7.66 \(\pm\) 0.22 & 6.06 \(\pm\) 0.11 & 67.81 \(\pm\) 0.04 \\ IR750+HA55 & 7.33 \(\pm\) 0.24 & 5.69 \(\pm\) 0.13 & 67.81 \(\pm\) 0.08 \\ IR750+HA70 & 6.44 \(\pm\) 0.09 & 4.70 \(\pm\) 0.07 & 67.79 \(\pm\) 0.02 \\ \hline \end{tabular}
\end{table} 
Table 6: The bioactive compounds of the dried samples in different strategies. \begin{table}
\begin{tabular}{c c c c c c c c c} \hline \hline
**S** & **T** & **I** & **AA** & **TPC** & **TFC** & **Deff** & **hm** & **n\({}_{\text{e}}\)** & **DE** & **SEC** \\ \hline \multirow{6}{*}{HA\_IR_IR_} & \multirow{2}{*}{55} & 250 & 67.53 \({}^{\text{bde}}\) & 6.71 \({}^{\text{fbi}}\) & 5.07 \({}^{\text{fbi}}\) & 3.13 \(\times\) 10\({}^{-10}\) ** & 1.98 \(\times\) 10\({}^{-8}\) ** & 4.19 \({}^{\text{m}}\) & 4.19 \({}^{\text{m}}\) & 49.77 \({}^{\text{b}}\) \\  & 40 & 500 & 67.36 \({}^{\text{cde}}\) & 6.05 \({}^{\text{f}}\) & 4.33 \({}^{\text{klmo}}\) & 3.92 \(\times\) 10\({}^{-10}\) ** & 2.71 \(\times\) 10\({}^{-8}\) ** & 4.30 \({}^{\text{m}}\) & 4.30 \({}^{\text{m}}\) & 48.86 \({}^{\text{b}}\) \\  & & 750 & 67.36 \({}^{\text{cde}}\) & 6.16 \